883
Views
32
CrossRef citations to date
0
Altmetric
Review

Immunological monitoring of anticancer vaccines in clinical trials

&
Article: e26012 | Received 12 Jul 2013, Accepted 02 Aug 2013, Published online: 23 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Charles Pottier, Alodie Wheatherspoon, Patrick Roncarati, Rémi Longuespée, Michael Herfs, Anaelle Duray, Philippe Delvenne & Pascale Quatresooz. (2015) The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Review of Anticancer Therapy 15:8, pages 943-954.
Read now
Pia T Johansen, Daniel Zucker, Ladan Parhamifar, Houman Pourhassan, Ditte Villum Madsen, Jonas R Henriksen, Monika Gad, Alcide Barberis, Roberto Maj, Thomas L Andresen & Simon S Jensen. (2015) Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist. Expert Opinion on Drug Delivery 12:7, pages 1045-1058.
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Fernando Baquero, Teresa M Coque & Rafael Cantón. (2014) Counteracting antibiotic resistance: breaking barriers among antibacterial strategies. Expert Opinion on Therapeutic Targets 18:8, pages 851-861.
Read now
Koichi Shimizu, Yoshihito Kotera, Atsushi Aruga, Nobuhiro Takeshita, Satoshi Katagiri, Shun-ichi Ariizumi, Yutaka Takahashi, Kenji Yoshitoshi, Ken Takasaki & Masakazu Yamamoto. (2014) Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma. Human Vaccines & Immunotherapeutics 10:4, pages 970-976.
Read now
Ryuji Okuyama, Atsushi Aruga, Takashi Hatori, Kazuyoshi Takeda & Masakazu Yamamoto. (2013) Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients. OncoImmunology 2:11.
Read now

Articles from other publishers (26)

Zheng Jin, Qin Zhou, Jia-Nan Cheng, Qingzhu Jia & Bo Zhu. (2023) Heterogeneity of the tumor immune microenvironment and clinical interventions. Frontiers of Medicine.
Crossref
Marcela Márquez, Karl Holmberg Olausson, Ayodele Alaiya, Sten Nilsson, Lennart Meurling & Anders R. Holmberg. (2022) Poly-guanidine shows high cytotoxicity in glioma cell cultures and glioma stem cells. Investigational New Drugs 40:3, pages 565-575.
Crossref
Bratislav M. Janjic, Aditi Kulkarni, Robert L. Ferris, Lazar Vujanovic & Nikola L. Vujanovic. (2022) Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands. Frontiers in Immunology 13.
Crossref
Ash Jay, Diedre Reitz, Satoshi H. Namekawa & Wolf-Dietrich Heyer. (2021) Cancer testis antigens and genomic instability: More than immunology. DNA Repair 108, pages 103214.
Crossref
Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu & Daofeng Tian. (2021) Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development. Frontiers in Genetics 12.
Crossref
Arjanneke F. van de Merbel, Geertje van der Horst & Gabri van der Pluijm. (2020) Patient-derived tumour models for personalized therapeutics in urological cancers. Nature Reviews Urology 18:1, pages 33-45.
Crossref
Haiqi Chen, Yu Jiang, Dolores D. Mruk & C. Yan Cheng. 2021. Molecular Mechanisms in Spermatogenesis. Molecular Mechanisms in Spermatogenesis 69 93 .
Tilahun Ayane Debele, Cheng-Fa Yeh & Wen-Pin Su. (2020) Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators. Cancers 12:12, pages 3773.
Crossref
Anne C. Conibear, Alanca Schmid, Meder Kamalov, Christian F.W. Becker & Claudia Bello. (2020) Recent Advances in Peptide-Based Approaches for Cancer Treatment. Current Medicinal Chemistry 27:8, pages 1174-1205.
Crossref
Yuan Mao, Weifei Fan, Hao Hu, Louqian Zhang, Jerod Michel, Yaqin Wu, Jun Wang, Lizhou Jia, Xiaojun Tang, Li Xu, Yan Chen, Jin Zhu, Zhenqing Feng, Lin Xu, Rong Yin & Qi Tang. (2019) MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells. Journal of Hematology & Oncology 12:1.
Crossref
Bryan S. Yung, Holly Pugh, Alison A. Generotti, Nikki Phanhthilath, Katherine Schultheis, Kar Muthumani, Kate E. Broderick & Trevor R.F. Smith. (2019) Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits. Vaccine 37:7, pages 903-909.
Crossref
Janna C. Nawroth, Riccardo Barrile, David Conegliano, Sander van Riet, Pieter S. Hiemstra & Remi Villenave. (2019) Stem cell-based Lung-on-Chips: The best of both worlds?. Advanced Drug Delivery Reviews 140, pages 12-32.
Crossref
Qingxue Sun, Matthias Barz, Bruno G. De Geest, Mustafa Diken, Wim E. Hennink, Fabian Kiessling, Twan Lammers & Yang Shi. (2019) Nanomedicine and macroscale materials in immuno-oncology. Chemical Society Reviews 48:1, pages 351-381.
Crossref
Saima Shakil Malik, Nosheen Masood, Iffat Fatima & Zehra Kazmi. 2019. Microbial Technology for the Welfare of Society. Microbial Technology for the Welfare of Society 53 82 .
David Urbanavicius, Tara Alvarez, Georgina K. Such, Angus P.R. Johnston & Justine D. Mintern. (2018) The potential of nanoparticle vaccines as a treatment for cancer. Molecular Immunology 98, pages 2-7.
Crossref
Qi Liu, Manisit Das, Yun Liu & Leaf Huang. (2018) Targeted drug delivery to melanoma. Advanced Drug Delivery Reviews 127, pages 208-221.
Crossref
Cheng Wang, Yayun Gu, Kai Zhang, Kaipeng Xie, Meng Zhu, Ningbin Dai, Yue Jiang, Xuejiang Guo, Mingxi Liu, Juncheng Dai, Linxiang Wu, Guangfu Jin, Hongxia Ma, Tao Jiang, Rong Yin, Yankai Xia, Li Liu, Shouyu Wang, Bin Shen, Ran Huo, Qianghu Wang, Lin Xu, Liuqing Yang, Xingxu Huang, Hongbing Shen, Jiahao Sha & Zhibin Hu. (2016) Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types. Nature Communications 7:1.
Crossref
Barbara Volz, Manuel Schmidt, Kerstin Heinrich, Kerstin Kapp, Matthias Schroff & Burghardt Wittig. (2016) Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist. Molecular Therapy - Oncolytics 3, pages 15023.
Crossref
Olivera J. Finn, Samir N. Khleif & Ronald B. Herberman. (2015) The FDA Guidance on Therapeutic Cancer Vaccines: The Need for Revision to Include Preventive Cancer Vaccines or for a New Guidance Dedicated to Them. Cancer Prevention Research 8:11, pages 1011-1016.
Crossref
Timothy J Zumwalt & Ajay Goel. (2015) Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives. Current Colorectal Cancer Reports 11:3, pages 125-140.
Crossref
Chizuru Ogi & Atsushi Aruga. (2015) Approaches to improve development methods for therapeutic cancer vaccines. Immunology Letters 164:2, pages 100-108.
Crossref
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, Christoph Huber, Giorgio Parmiani, Suzy Scholl, Nicholas Thatcher, John Wagstaff, Christoph Zielinski, Ian Faulkner & Håkan Mellstedt. (2014) Therapeutic vaccines for cancer: an overview of clinical trials. Nature Reviews Clinical Oncology 11:9, pages 509-524.
Crossref
Serena Chang, Holbrook Kohrt & Holden T. Maecker. (2014) Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunology, Immunotherapy 63:7, pages 713-719.
Crossref
Hadeel Khallouf, Agnieszka Grabowska & Angelika Riemer. (2014) Therapeutic Vaccine Strategies against Human Papillomavirus. Vaccines 2:2, pages 422-462.
Crossref
Richard G Everson, Richard M Jin, Xiaoyan Wang, Michael Safaee, Rudi Scharnweber, Dominique N Lisiero, Horacio Soto, Linda M Liau & Robert M Prins. (2014) Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal for ImmunoTherapy of Cancer 2:1, pages 10.
Crossref
Victoria L. Martucci & Karel Pacak. (2014) Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment. Current Problems in Cancer 38:1, pages 7-41.
Crossref